Wellkasa Inc.

Raising money for expanding sales and marketing

Facebook Twitter LinkedIn

SaaS & ecommerce MedTech company delivering symptom-specific supplements for chronic medical conditions. 

KEY POINTS
  • Wellkasa is a two year old MedTech company focused on improving the “quality of life” for chronic disease patients.
  • In two years, Wellkasa has built a combination of proprietary supplements and wellness SAAS solutions that are unique and serve significant unmet market needs. An example of that is our first solution - Migra-Well line of supplements which targets 39 million US migraine sufferers, where only 8% are getting the comprehensive care. 
  • We have initial traction through key partnerships and consumer adoption.
  • We have built a high-profile Medical Advisory Board with Doctors from UCSF, Baylor and other reputed medical institutions
  • Founder and CEO is a seasoned veteran who ran a $500 million division of multi-billion-dollar public company, he has built a strong team to execute his visions.
OPPORTUNITY
Wellkasa solutions target more than 100 million people in the U.S. affected by chronic medical conditions who struggle with finding safe and effective supplements for symptom relief or prevention. In its first offering, Wellkasa is focused on the unmet needs of 39 million US migraine sufferers of which only 8% receive adequate care for their conditions.

SOLUTION
Formulated by Headache Specialist MD, Wellkasa has developed, Migra-Well line of migraine nutrient and anti-inflammatory supplements. The ingredients are backed by 46  research papers and 30 years of MD's clinical experience.  Migra-Well comes with WellKabinet, a digital medicine cabinet, which enables patients to organize all their supplements and prescriptions, auto-check for interactions  and track migraine symptoms. WellKabinet also acts as a membership offering supplement discounts & free shipping.  

INVESTMENT HIGHLIGHTS
Target: $24B US supplement market for chronic conditions, growing at 8%.

Offering: Doctor-formulated premium supplements with proprietary digital medicine cabinet & symptom tracker. 

Developed & Launched: WellKabinet   & Migra-Well supplements for migraines. 

Revenue: $41K from 400+ customers in 49 states over 2022 market test pilot. 

Growth Plan: Go to market strategy in place to acquire 10K customers in 2023.

Team: Top doctors, seasoned executives and tech entrepreneurs.

$2M Seed: Funds 18 months runway, 10K customers and $10M sales run-rate with inventory build and growth investments

Ready to Ask For Funding for your company?

Post a Funding Request

Wellkasa Inc. is no longer seeking funding.